TransCode Therapeutics Announces Safety Review Committee Approval of Second Cohort Opening in Phase 1 TTX-MC138 Clinical Trial Following Favorable Review of Cohort 1 Safety Data
23 oct. 2024 07h00 HE
|
TransCode Therapeutics, Inc.
TransCode Therapeutics Announces Safety Review Committee Approval of Second Cohort Opening in Phase 1 TTX-MC138 Clinical Trial Following Favorable Review o
Cytosurge and Lexogen Partner to Advance Live-Cell Sequencing
15 oct. 2024 09h00 HE
|
Cytosurge AG; Lexogen GmbH
Cytosurge and Lexogen partner to advance Live-seq, integrating FluidFM® and LUTHOR HD to enable scalable, live-cell transcriptomics with high sensitivity.
Nucleic Acid Therapeutics CDMO Industry Outlook, 2024-2030 - Increasing Demand for One-Stop-Shop CDMOs and Growing FDIs in Nucleic Acid Therapeutics
10 oct. 2024 12h30 HE
|
Research and Markets
Dublin, Oct. 10, 2024 (GLOBE NEWSWIRE) -- The "Nucleic Acid Therapeutics CDMO Market Size, Share & Trends Analysis, 2024-2030" report has been added to ResearchAndMarkets.com's offering.The...
RNA Sequencing Market Opportunities - Harnessing Blockchain and Cloud Computing Technologies and Technological Advances in RNA Isolation and Extraction Processes
07 oct. 2024 05h08 HE
|
Research and Markets
Dublin, Oct. 07, 2024 (GLOBE NEWSWIRE) -- The "RNA Sequencing: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. This research report covers the global...
TransCode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial with First-in-Class Lead Therapeutic Candidate
17 sept. 2024 07h00 HE
|
TransCode Therapeutics, Inc.
TransCode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial with First-in-Class Lead Therapeutic Candidate
TransCode Therapeutics Awarded $2 Million NIH Grant to Support Clinical Evaluation of Lead Candidate
05 sept. 2024 07h00 HE
|
TransCode Therapeutics, Inc.
TransCode Therapeutics Awarded $2 Million NIH Grant to Support Clinical Evaluation of Lead Candidate
U.S. Epigenetics Market Size, Share & Trends Analysis Forecast Report 2024-2030, Featuring Roche Diagnostics, Danaher, Novartis, Element Biosciences, Dovetail Genomics, Illumina, Promega and Abcam
04 sept. 2024 09h21 HE
|
Research and Markets
Dublin, Sept. 04, 2024 (GLOBE NEWSWIRE) -- The "U.S. Epigenetics Market Size, Share & Trends Analysis Report by Product (Reagents, Kits), Technology (DNA Methylation, Histone Methylation),...
gRNA Industry Research Report 2024: Size, Share, Trends, Opportunities, and Forecasts, 2019-2029F
03 sept. 2024 09h39 HE
|
Research and Markets
Dublin, Sept. 03, 2024 (GLOBE NEWSWIRE) -- The "gRNA Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F" report has been added to ResearchAndMarkets.com's...
RNAi Market and Technologies Industry Report 2024, with Company Profiles of Major Players including Alnylam Pharmaceuticals, Novartis, Thermo Fisher Scientific and Revvity
23 août 2024 04h02 HE
|
Research and Markets
Dublin, Aug. 23, 2024 (GLOBE NEWSWIRE) -- The "RNAi Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.The global market for RNAi technology is estimated to...
RNA Analysis / Transcriptomics Strategic Research Report 2023-2030: Drug Discovery Segment Poised to Lead, North America Emerges as the Major Regional Market
19 août 2024 04h06 HE
|
Research and Markets
Dublin, Aug. 19, 2024 (GLOBE NEWSWIRE) -- The "RNA Analysis / Transcriptomics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...